These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 3862339)

  • 21. Dilemma of immunosuppression and infection risk in systemic lupus erythematosus.
    He J; Li Z
    Rheumatology (Oxford); 2023 Mar; 62(Suppl 1):i22-i29. PubMed ID: 36987605
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Acute myeloid leukemia developing in patients with autoimmune diseases.
    Ramadan SM; Fouad TM; Summa V; Hasan SKh; Lo-Coco F
    Haematologica; 2012 Jun; 97(6):805-17. PubMed ID: 22180424
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Treatment of lupus nephritis.
    Donadio JV
    Nephron; 1977; 19(4):186-9. PubMed ID: 917164
    [No Abstract]   [Full Text] [Related]  

  • 24. [Systemic lupus erythematosus and end-stage chronic renal insufficiency. Therapeutic perspectives].
    Font J; Campistol JM
    Med Clin (Barc); 1989 Apr; 92(15):573-6. PubMed ID: 2666771
    [No Abstract]   [Full Text] [Related]  

  • 25. [Immunosuppression in systemic lupus erythematosus. Effect of cyclophosphamide and corticoids on lymphocyte subpopulations].
    Fuks A; Carballal G; Manni JA
    Medicina (B Aires); 1979; 39(3):289-97. PubMed ID: 514050
    [No Abstract]   [Full Text] [Related]  

  • 26. [Lupus enteritis: an uncommon manifestation of systemic lupus erythematosus with favourable outcome on corticosteroids].
    Thomas G; Ebbo M; Genot S; Bernit E; Mazodier K; Veit V; Lagrange X; Heyries L; Kaplanski G; Schleinitz N; Harlé JR
    Rev Med Interne; 2010 Jul; 31(7):493-7. PubMed ID: 20471141
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Abetimus sodium for renal flare in systemic lupus erythematosus: results of a randomized, controlled phase III trial.
    Cardiel MH; Tumlin JA; Furie RA; Wallace DJ; Joh T; Linnik MD;
    Arthritis Rheum; 2008 Aug; 58(8):2470-80. PubMed ID: 18668592
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Bone marrow as a target organ of systemic lupus erythematosus: analysis of cases with myelofibrosis.
    Üsküdar Cansu D; Üsküdar Teke H; Işiksoy S; Korkmaz C
    Int J Rheum Dis; 2018 May; 21(5):1049-1059. PubMed ID: 29671953
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Lupus mesenteric vasculitis: clinical features and associated factors for the recurrence and prognosis of disease.
    Yuan S; Ye Y; Chen D; Qiu Q; Zhan Z; Lian F; Li H; Liang L; Xu H; Yang X
    Semin Arthritis Rheum; 2014 Jun; 43(6):759-66. PubMed ID: 24332116
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Pulmonary nocardiosis. Occurrence in men with systemic lupus erythematosus.
    Gorevic PD; Katler EI; Agus B
    Arch Intern Med; 1980 Mar; 140(3):361-3. PubMed ID: 7362355
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Cyclosporin therapy of patients with systemic lupus erythematosus].
    Gergely P
    Orv Hetil; 1994 Nov; 135(47):2591-5. PubMed ID: 7824258
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Corticosteroids and systemic lupus erythematosus pancreatitis: a case series.
    Saab S; Corr MP; Weisman MH
    J Rheumatol; 1998 Apr; 25(4):801-6. PubMed ID: 9558190
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Neurological presentation of systemic lupus erythematosus].
    Romero-López J; Moreno-Carretero MJ; Escriche-Jaime D
    Rev Neurol; 1996 Oct; 24(134):1276-8. PubMed ID: 8983729
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Corticosteroid dose and the risk of opportunistic infection in a national systemic lupus erythematosus cohort.
    Yang SC; Lai YY; Huang MC; Tsai CS; Wang JL
    Lupus; 2018 Oct; 27(11):1819-1827. PubMed ID: 30103646
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Successful treatment of interstitial lung disease in systemic lupus erythematosus with methotrexate.
    Fink SD; Kremer JM
    J Rheumatol; 1995 May; 22(5):967-9. PubMed ID: 8587090
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Psoriasis and systemic lupus erythematosus: a rare association with specific therapeutic problems].
    Astudillo L; Sailler L; Carreiro M; Dahan S; Ollier S; Arlet P
    Ann Med Interne (Paris); 2003 Feb; 154(1):3-6. PubMed ID: 12746653
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Infections in systemic lupus erythematosus].
    Massardo L; Martínez ME; Baro M; Figueroa F; Rivero S; Jacobelli S
    Rev Med Chil; 1991 Oct; 119(10):1115-22. PubMed ID: 1845204
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Malignancy in Systemic Lupus Erythematosus (SLE) Patients.
    Cader RA; Mei Yee AK; Yassin A; Ahmad I; Haron SN
    Asian Pac J Cancer Prev; 2018 Dec; 19(12):3551-3555. PubMed ID: 30583682
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The shrinking lung syndrome in systemic lupus erythematosus: improvement with corticosteroid therapy.
    Oud KT; Bresser P; ten Berge RJ; Jonkers RE
    Lupus; 2005; 14(12):959-63. PubMed ID: 16425576
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Perspectives on the changing face of lupus mortality.
    Vasoo S; Hughes GR
    Autoimmun Rev; 2004 Aug; 3(6):415-7. PubMed ID: 15351307
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.